FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982224893> ?p ?o ?g. }

• W1982224893 endingPage "785" @default.
• W1982224893 startingPage "785" @default.
• W1982224893 abstract "The aim of this study was to evaluate the efficacy of levofloxacin and rifaximin based quadruple regimen as first-line treatment for Helicobacter pylori infection. A prospectively randomized, double-blinded, parallel group, comparative study was performed. Three hundred consecutive H. pylori positive patients were randomized to receive: omeprazole, amoxicillin, clarithromycin (OAC); omeprazole, amoxicillin, levofloxacin (OAL); and omeprazole, amoxicillin, levofloxacin, rifaximin (OAL-R). The eradication rates in the intention to treat (ITT) and per protocol (PP) analyses were: OAC, 77.8% and 85.6%; OAL, 65.3% and 73.6%; and OAL-R, 74.5% and 80.2%. The eradication rate achieved with OAC was higher than with OAL on the ITT (P = 0.05) and PP analysis (P = 0.04). OAL-R regimen was not inferior to OAC. The frequency of moderate to severe adverse effects was significantly higher in OAC treatment group. Especially, diarrhea was most common complaint, and there was a significantly low rate of moderate to severe diarrhea with the rifaximin containing regimen. In conclusion, the levofloxacin and rifaximin based regimen comes up to the standard triple therapy, but has a limited efficacy in a Korean cohort. The rifaximin containing regimen has a very high safety profile for H. pylori eradication therapy." @default.
• W1982224893 created "2016-06-24" @default.
• W1982224893 creator A5007137417 @default.
• W1982224893 creator A5018503481 @default.
• W1982224893 creator A5022918002 @default.
• W1982224893 creator A5035881329 @default.
• W1982224893 creator A5041254617 @default.
• W1982224893 creator A5043849525 @default.
• W1982224893 creator A5053023634 @default.
• W1982224893 creator A5073851688 @default.
• W1982224893 date "2011-01-01" @default.
• W1982224893 modified "2023-10-16" @default.
• W1982224893 title "Efficacy of Levofloxacin and Rifaximin based Quadruple Therapy in Helicobacter pylori Associated Gastroduodenal Disease: A Double-Blind, Randomized Controlled Trial" @default.
• W1982224893 cites W1590686299 @default.
• W1982224893 cites W1965080494 @default.
• W1982224893 cites W1969507965 @default.
• W1982224893 cites W1972248676 @default.
• W1982224893 cites W1974497208 @default.
• W1982224893 cites W1983952263 @default.
• W1982224893 cites W1990055354 @default.
• W1982224893 cites W1990841393 @default.
• W1982224893 cites W1996405559 @default.
• W1982224893 cites W2013134902 @default.
• W1982224893 cites W2034837410 @default.
• W1982224893 cites W2057483058 @default.
• W1982224893 cites W2061938579 @default.
• W1982224893 cites W2075697365 @default.
• W1982224893 cites W2081721924 @default.
• W1982224893 cites W2101730203 @default.
• W1982224893 cites W2101950652 @default.
• W1982224893 cites W2102924171 @default.
• W1982224893 cites W2104172162 @default.
• W1982224893 cites W2121396603 @default.
• W1982224893 cites W2134300124 @default.
• W1982224893 cites W2136210283 @default.
• W1982224893 cites W2139295327 @default.
• W1982224893 cites W2144987107 @default.
• W1982224893 cites W2148899552 @default.
• W1982224893 cites W2153165213 @default.
• W1982224893 cites W4236254852 @default.
• W1982224893 doi "https://doi.org/10.3346/jkms.2011.26.6.785" @default.
• W1982224893 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3102873" @default.
• W1982224893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21655065" @default.
• W1982224893 hasPublicationYear "2011" @default.
• W1982224893 type Work @default.
• W1982224893 sameAs 1982224893 @default.
• W1982224893 citedByCount "28" @default.
• W1982224893 countsByYear W19822248932012 @default.
• W1982224893 countsByYear W19822248932013 @default.
• W1982224893 countsByYear W19822248932014 @default.
• W1982224893 countsByYear W19822248932015 @default.
• W1982224893 countsByYear W19822248932016 @default.
• W1982224893 countsByYear W19822248932017 @default.
• W1982224893 countsByYear W19822248932018 @default.
• W1982224893 countsByYear W19822248932020 @default.
• W1982224893 countsByYear W19822248932021 @default.
• W1982224893 countsByYear W19822248932022 @default.
• W1982224893 countsByYear W19822248932023 @default.
• W1982224893 crossrefType "journal-article" @default.
• W1982224893 hasAuthorship W1982224893A5007137417 @default.
• W1982224893 hasAuthorship W1982224893A5018503481 @default.
• W1982224893 hasAuthorship W1982224893A5022918002 @default.
• W1982224893 hasAuthorship W1982224893A5035881329 @default.
• W1982224893 hasAuthorship W1982224893A5041254617 @default.
• W1982224893 hasAuthorship W1982224893A5043849525 @default.
• W1982224893 hasAuthorship W1982224893A5053023634 @default.
• W1982224893 hasAuthorship W1982224893A5073851688 @default.
• W1982224893 hasBestOaLocation W19822248931 @default.
• W1982224893 hasConcept C126322002 @default.
• W1982224893 hasConcept C141071460 @default.
• W1982224893 hasConcept C168563851 @default.
• W1982224893 hasConcept C197934379 @default.
• W1982224893 hasConcept C2776409635 @default.
• W1982224893 hasConcept C2776962512 @default.
• W1982224893 hasConcept C2777498785 @default.
• W1982224893 hasConcept C2778375690 @default.
• W1982224893 hasConcept C2778889925 @default.
• W1982224893 hasConcept C2779708577 @default.
• W1982224893 hasConcept C2781276175 @default.
• W1982224893 hasConcept C2781413609 @default.
• W1982224893 hasConcept C501593827 @default.
• W1982224893 hasConcept C71924100 @default.
• W1982224893 hasConcept C86803240 @default.
• W1982224893 hasConcept C89423630 @default.
• W1982224893 hasConcept C90924648 @default.
• W1982224893 hasConceptScore W1982224893C126322002 @default.
• W1982224893 hasConceptScore W1982224893C141071460 @default.
• W1982224893 hasConceptScore W1982224893C168563851 @default.
• W1982224893 hasConceptScore W1982224893C197934379 @default.
• W1982224893 hasConceptScore W1982224893C2776409635 @default.
• W1982224893 hasConceptScore W1982224893C2776962512 @default.
• W1982224893 hasConceptScore W1982224893C2777498785 @default.
• W1982224893 hasConceptScore W1982224893C2778375690 @default.
• W1982224893 hasConceptScore W1982224893C2778889925 @default.
• W1982224893 hasConceptScore W1982224893C2779708577 @default.
• W1982224893 hasConceptScore W1982224893C2781276175 @default.
• W1982224893 hasConceptScore W1982224893C2781413609 @default.
• W1982224893 hasConceptScore W1982224893C501593827 @default.

• next